NORTHWOOD, Ohio–(BUSINESS WIRE)–Mar 8, 2012– NAMSA, a leading medical device research organization, recently announced the opening of its newest office near Frankfurt, Germany. Staff with regulatory and quality expertise, clinical managers, and local monitors provide ideal support for European clinical trials as well as European device makers seeking US approvals.
“US companies can have confidence that the high quality support they’ve valued in NAMSA’s US clinical and consulting operations are now available in Europe, ensuring the same responsiveness and thoroughness on both sides of ‘the pond,'” said Elizabeth Kempen, COO of NAMSA’s Clinical Research and Consulting groups. European market approval has emerged as a preferred pathway for medical device manufacturers primarily due to more efficient approval processes. “The placement of this office reinforces NAMSA’s commitment to helping our clients design and execute global regulatory and clinical strategies, develop new therapies, and launch them in the most efficient manner possible,” said John Gorski, NAMSA’s President and CEO.
NAMSA’s testing laboratory near Lyon, France (Biomatech) has been conducting non-clinical safety and efficacy studies for medical device companies since 1986. “The combination of non-clinical and clinical research expertise at our European locations enables NAMSA to provide our clients with a higher level of continuity, consistency and convenience throughout the product development process,” Gorski concluded.
About NAMSA NAMSA ( www.namsa.com ) is a global medical device research organization providing a comprehensive range of services to prove efficacy, non-clinical and clinical safety of medical devices, IVDs and combination products. For more than 45 years, NAMSA clients have utilized its testing and consulting services to bring safe and effective therapies to market.
Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid50197799&langen CONTACT: NAMSA Tim Blair, +1 763-287-3830 Director of Business Development tblair@namsa.com KEYWORD: UNITED STATES EUROPE NORTH AMERICA MINNESOTA GERMANY OHIO INDUSTRY KEYWORD: PRACTICE MANAGEMENT HEALTH BIOTECHNOLOGY HOSPITALS MEDICAL DEVICES MEDICAL SUPPLIES SOURCE: NAMSA Copyright Business Wire 2012 PUB: 03/08/2012 02:46 PM/DISC: 03/08/2012 02:46 PM http://www.businesswire.com/news/home/20120308006325/